Executives from the Scandinavian and German biotech
industries participated in the course on Valuation, Deal
Structuring and Negotiation in life science.
Key take-home messages from the course was:
- Understanding of financial terms such as discount rate,
DCF, rNPV, IRR and hurdle rate
- Background of the Top-3 project value drivers and methods
for estimating them
- Understanding of and experience in using key valuation and
deal structuring methods
- Do's and don'ts in deal negotiations
- Experience in preparing efficient
negotiation strategies
The faculty included senior licensing executives from Novo
Nordisk A/S and Bavarian Nordic A/S who provided key insights
into licensing practices in biotech and pharma.
Copyright © 2017 Wiborg ApS. All rights reserved.